What they were paid
Jade Biosciences Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $21,250 | — | $0 | $0 | $21,250 |
| FY2023 | $20,000 | $0 | $343,250 | $0 | $363,250 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Jade Biosciences, Inc. DEF 14A filed April 28, 2026, accession 0001193125-26-187059, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Jade Biosciences pays directors a $40,000 cash retainer and $35,000 in Options.
The rest of the Jade Biosciences board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Chris Cain | Independent Director | $205,672 |
| Christopher Cain, Ph.D | Independent Director | — |
| Eric Dobmeier, J.D | Independent Director | $226,935 |
| Erin Lavelle | Independent Director | $212,422 |
| Lawrence Klein, Ph.D | Independent Director | $210,059 |
| Tom Frohlich | Director | $0 |
| Tomas Kiselak | Independent Director | $206,347 |
The full Jade Biosciences compensation record
free company briefThis page is one director within Jade Biosciences's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat